Lineage Cell Therapeutics, Inc. Depreciation
Lineage Cell Therapeutics, Inc. (LCTX) reported Depreciation of $996.00 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2016-11-04
- Lineage Cell Therapeutics, Inc. depreciation for the quarter ending 2016-09-30 was $248.00K, a 6.06% decline year-over-year.
- Lineage Cell Therapeutics, Inc. depreciation for the quarter ending 2016-06-30 was $319.00K, a 28.11% increase year-over-year.
- Lineage Cell Therapeutics, Inc. depreciation for the quarter ending 2016-03-31 was $429.00K, a 63.12% increase year-over-year.
- Lineage Cell Therapeutics, Inc. depreciation for the quarter ending 2015-12-31 was $302.00K, a 17.51% increase year-over-year.
- Lineage Cell Therapeutics, Inc. depreciation for fiscal 2015 was $1.08M, a 2.57% increase from fiscal 2014.
- Lineage Cell Therapeutics, Inc. depreciation for fiscal 2014 was $1.05M, a 59.97% increase from fiscal 2013.
- Lineage Cell Therapeutics, Inc. depreciation for fiscal 2013 was $657.00K, a 70.01% increase from fiscal 2012.
- Lineage Cell Therapeutics, Inc. depreciation for fiscal 2012 was $386.46K, a 3.51% increase from fiscal 2011.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | $248.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $567.00K derived: sum of 2 quarters · filed 2016-11-04 | $996.00K 10-Q · filed 2016-11-04 | $1.30M derived: sum of 4 quarters · filed 2016-11-04 | ||||
| 2016-06-30 | $319.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $748.00K 10-Q · filed 2016-08-09 | $1.05M derived: sum of 3 quarters · filed 2016-08-09 | $1.31M derived: sum of 4 quarters · filed 2016-11-04 | ||||
| 2016-03-31 | $429.00K 10-Q · filed 2016-05-10 | $731.00K derived: sum of 2 quarters · filed 2016-05-10 | $995.00K derived: sum of 3 quarters · filed 2016-11-04 | $1.24M derived: sum of 4 quarters · filed 2016-11-04 | ||||
| 2015-12-31 | $302.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $566.00K derived: sum of 2 quarters · filed 2016-11-04 | $815.00K derived: sum of 3 quarters · filed 2016-11-04 | $1.08M 10-K · filed 2016-03-15 | ||||
| 2015-09-30 | $264.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $513.00K derived: sum of 2 quarters · filed 2016-11-04 | $776.00K 10-Q · filed 2016-11-04 | $1.03M derived: sum of 4 quarters · filed 2016-11-04 | ||||
| 2015-06-30 | $249.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $512.00K 10-Q · filed 2016-08-09 | $769.00K derived: sum of 3 quarters · filed 2016-08-09 | $1.04M derived: sum of 4 quarters · filed 2016-08-09 | ||||
| 2015-03-31 | $263.00K 10-Q · filed 2016-05-10 | $262.60K 10-Q · filed 2015-05-08 | $520.00K derived: sum of 2 quarters · filed 2016-05-10 | $791.00K derived: sum of 3 quarters · filed 2016-05-10 | $1.06M derived: sum of 4 quarters · filed 2016-05-10 | |||
| 2014-12-31 | $257.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $528.00K derived: sum of 2 quarters · filed 2016-03-15 | $794.05K derived: sum of 3 quarters · filed 2016-03-15 | $1.05M 10-K · filed 2016-03-15 | $1.05M 10-K · filed 2015-03-11 | |||
| 2014-09-30 | $271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $537.05K derived: sum of 2 quarters · filed 2015-11-09 | $794.00K 10-Q · filed 2015-11-09 | $794.41K 10-Q · filed 2014-11-07 | $1.03M derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-06-30 | $266.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $523.00K 10-Q · filed 2015-08-10 | $522.71K 10-Q · filed 2014-08-11 | $760.37K derived: sum of 3 quarters · filed 2016-03-15 | $1.18M derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-03-31 | $256.94K 10-Q · filed 2015-05-08 | $494.31K derived: sum of 2 quarters · filed 2016-03-15 | $913.95K derived: sum of 3 quarters · filed 2016-03-15 | $1.03M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | $237.37K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $657.00K derived: sum of 2 quarters · filed 2016-03-15 | $770.36K derived: sum of 3 quarters · filed 2016-03-15 | $657.00K 10-K · filed 2016-03-15 | $656.76K 10-K · filed 2014-03-17 | |||
| 2013-09-30 | $419.63K 10-Q · filed 2014-11-07 | $532.99K derived: sum of 2 quarters · filed 2014-11-07 | $419.63K 10-Q · filed 2014-11-07 | $749.16K derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-06-30 | $113.36K 10-Q · filed 2013-08-09 | $253.22K 10-Q · filed 2014-08-11 | $329.53K derived: sum of 3 quarters · filed 2015-03-11 | $429.19K derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-03-31 | $113.36K 10-Q · filed 2014-05-12 | $216.18K derived: sum of 2 quarters · filed 2015-03-11 | $315.83K derived: sum of 3 quarters · filed 2015-03-11 | $404.52K derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2012-12-31 | $102.82K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $202.48K derived: sum of 2 quarters · filed 2015-03-11 | $291.17K derived: sum of 3 quarters · filed 2015-03-11 | $386.46K 10-K · filed 2015-03-11 | ||||
| 2012-09-30 | $99.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $188.35K derived: sum of 2 quarters · filed 2013-11-12 | $283.64K 10-Q · filed 2013-11-12 | $389.74K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-06-30 | $88.69K 10-Q · filed 2013-08-09 | $183.98K 10-Q · filed 2013-08-09 | $290.09K derived: sum of 3 quarters · filed 2014-03-17 | $422.52K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-03-31 | $88.69K 10-Q · filed 2013-05-10 | $201.40K derived: sum of 2 quarters · filed 2014-03-17 | $333.83K derived: sum of 3 quarters · filed 2014-03-17 | $396.80K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2011-12-31 | $112.70K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $245.13K derived: sum of 2 quarters · filed 2014-03-17 | $308.11K derived: sum of 3 quarters · filed 2014-03-17 | $373.35K 10-K · filed 2014-03-17 | ||||
| 2011-09-30 | $132.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $195.40K derived: sum of 2 quarters · filed 2012-11-09 | $260.65K 10-Q · filed 2012-11-09 | $335.41K derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-06-30 | $62.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $128.22K 10-Q · filed 2012-08-09 | $202.98K derived: sum of 3 quarters · filed 2013-03-18 | $235.65K derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-03-31 | $65.24K 10-Q · filed 2012-05-10 | $140.01K derived: sum of 2 quarters · filed 2013-03-18 | $172.68K derived: sum of 3 quarters · filed 2013-03-18 | |||||
| 2010-12-31 | $74.77K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $107.44K derived: sum of 2 quarters · filed 2013-03-18 | $138.66K 10-K · filed 2013-03-18 | |||||
| 2010-09-30 | $32.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $63.89K 10-Q · filed 2011-11-08 | ||||||
| 2010-06-30 | $31.22K 10-Q · filed 2011-08-09 | |||||||
| 2009-12-31 | $34.59K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |